⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
POLICYBZR - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 2.7
| Stock Code | POLICYBZR | Market Cap | 71,301 Cr. | Current Price | 1,541 ₹ | High / Low | 1,978 ₹ |
| Book Value | 175 ₹ | Dividend Yield | 0.00 % | ROCE | -0.03 % | ROE | -0.03 % |
| Face Value | 2.00 ₹ | DMA 50 | 1,560 ₹ | DMA 200 | 1,682 ₹ | Chg in FII Hold | -2.87 % |
| Chg in DII Hold | 2.91 % | PAT Qtr | 15.8 Cr. | PAT Prev Qtr | 0.69 Cr. | RSI | 55.3 |
| MACD | -20.3 | Volume | 9,55,264 | Avg Vol 1Wk | 11,49,265 | Low price | 1,334 ₹ |
| High price | 1,978 ₹ | Debt to equity | 0.00 | 52w Index | 32.1 % | Qtr Profit Var | 13.1 % |
| EPS | 0.17 ₹ | Industry PE | 20.9 |
📊 Financial Overview
- Revenue & Profitability: Quarterly PAT improved to ₹15.8 Cr. from ₹0.69 Cr., but overall profitability remains weak. ROE (-0.03%) and ROCE (-0.03%) are negative, showing poor efficiency.
- Debt & Liquidity: Debt-to-equity at 0.00 indicates zero leverage, but cash flows remain fragile due to low earnings.
- Valuation: No meaningful P/E ratio due to negligible earnings. P/B ~8.8 indicates expensive valuation relative to book value. PEG ratio unavailable, reflecting uncertain growth visibility.
- Technical Indicators: RSI at 55.3 shows neutral momentum; MACD at -20.3 indicates bearish trend. Current price ₹1,541 is below DMA 50 (₹1,560) and DMA 200 (₹1,682), signaling weakness.
🏢 Business Model & Competitive Advantage
- Policybazaar operates as an online insurance and financial services marketplace, offering comparison and distribution of insurance products.
- Competitive advantage lies in strong brand recognition, large customer base, and digital-first model, but profitability remains a challenge.
💡 Entry Zone Recommendation
- Entry zone: ₹1,350–₹1,500, closer to support levels.
- High risk due to weak fundamentals; suitable only for speculative investors betting on long-term digital insurance adoption.
📈 Long-Term Holding Guidance
- Not suitable for conservative long-term holding until profitability stabilizes.
- Upside potential tied to insurance penetration growth and digital adoption in India.
✅ Positive
- Quarterly PAT improved significantly from ₹0.69 Cr. to ₹15.8 Cr.
- Zero debt-to-equity ratio ensures financial flexibility.
- DII holdings increased (+2.91%).
⚠️ Limitation
- Negative ROE (-0.03%) and ROCE (-0.03%).
- No dividend yield.
- P/B ratio (~8.8) indicates expensive valuation.
📉 Company Negative News
- Weak profitability despite PAT improvement.
- Bearish technical indicators (MACD negative, price below DMA 200).
- FII holdings reduced (-2.87%).
📈 Company Positive News
- DII holdings increased (+2.91%).
- Quarterly PAT growth shows early signs of improvement.
- Strong brand presence in digital insurance marketplace.
🏭 Industry
- Insurance/fintech industry P/E at 20.9, but Policybazaar has no meaningful P/E due to weak earnings.
- Sector growth driven by rising insurance penetration and digital adoption in India.
🔎 Conclusion
- Policybazaar has strong brand presence and growing relevance in digital insurance but remains overvalued with weak fundamentals.
- Entry only near ₹1,350–₹1,500 for speculative investors; long-term holding not recommended until profitability improves.